These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37592306)

  • 1. Identifying barriers and facilitators along the hepatitis C care cascade to inform human-centered design of contextualized treatment protocols for vulnerable populations in Austin, Texas: a qualitative study.
    Desai A; O'Neal L; Reinis K; Brown C; Stefanowicz M; Kuang A; Agrawal D; Bhavnani D; Mercer T
    Implement Sci Commun; 2023 Aug; 4(1):98. PubMed ID: 37592306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, implementation, and feasibility of site-specific hepatitis C virus treatment workflows for treating vulnerable, high-risk populations: protocol of the Erase Hep C study - a prospective single-arm intervention trial.
    Desai A; O'Neal L; Reinis K; Chang P; Brown C; Stefanowicz M; Kuang A; Agrawal D; Bhavnani D; Mercer T
    Pilot Feasibility Stud; 2023 May; 9(1):78. PubMed ID: 37158965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative investigation of organizational challenges and facilitators to screening individuals experiencing homelessness for hepatitis C virus (HCV) in Houston, Texas.
    Celeste-Villalvir A; Wilkerson JM; Markham C; Rodriguez L; Schick V
    PLoS One; 2022; 17(8):e0273302. PubMed ID: 35994438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugs.
    Austin EJ; Gojic AJ; Bhatraju EP; Pierce KA; Pickering EI; Tung EL; Scott JD; Hansen RN; Glick SN; Stekler JD; Connolly NC; Villafuerte S; McPadden M; Deutsch S; Ninburg M; Kubiniec R; Williams EC; Tsui JI
    Int J Drug Policy; 2023 Jan; 111():103924. PubMed ID: 36521197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative investigation of the barriers and facilitators to Hepatitis C virus (HCV) screening among individuals experiencing homelessness in Houston, Texas.
    Celeste-Villalvir A; Wilkerson JM; Markham C; Rodriguez L; Schick V
    Dialogues Health; 2022 Dec; 1():100058. PubMed ID: 38515888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis.
    Amoako A; Ortiz-Paredes D; Engler K; Lebouché B; Klein MB
    Int J Drug Policy; 2021 Oct; 96():103247. PubMed ID: 33853727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT-An integrated community hepatitis C service.
    Phillips C; Schulkind J; O'Sullivan M; Edelman N; Smith HE; Verma S; Jones CJ
    J Viral Hepat; 2020 Feb; 27(2):176-187. PubMed ID: 31566851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "I want to feel young again": experiences and perspectives of young people who inject drugs living with hepatitis C in Vancouver, Canada.
    Jacob J; Goodyear T; Coulaud PJ; Hoong P; Ti L; Knight R
    Can J Public Health; 2021 Oct; 112(5):947-956. PubMed ID: 34115340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives.
    Surratt HL; Yeager HJ; Adu A; González EA; Nelson EO; Walker T
    Front Psychiatry; 2022; 13():905314. PubMed ID: 35706473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities.
    Versfeld A; McBride A; Scheibe A; Spearman CW
    Harm Reduct J; 2020 Jun; 17(1):39. PubMed ID: 32522210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.
    Tsui JI; Barry MP; Austin EJ; Sweek EW; Tung E; Hansen RN; Ninburg M; Scott JD; Glick SN; Williams EC
    Addict Sci Clin Pract; 2021 Aug; 16(1):52. PubMed ID: 34384494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis.
    Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Bajis S; Valencia BM; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J
    Int J Drug Policy; 2023 Jan; 111():103917. PubMed ID: 36542883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Not just one box that you tick off' - Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective.
    Marshall AD; Rance J; Grebely J; Treloar C
    Int J Drug Policy; 2022 Apr; 102():103610. PubMed ID: 35151085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clients' perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters.
    Masson CL; Fokuo JK; Anderson A; Powell J; Zevin B; Bush D; Khalili M
    BMC Infect Dis; 2020 May; 20(1):386. PubMed ID: 32471376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived patient navigator services and characteristics to address barriers to linkage to hepatitis C care among people released from provincial prison in Quebec, Canada.
    Kronfli N; Mambro A; Riback LR; Ortiz-Paredes D; Dussault C; Chalifoux S; Del Balso L; Petropoulos A; Lim M; Halavrezos A; Sebastiani G; Klein MB; Lebouche B; Cox J; Akiyama MJ
    Int J Drug Policy; 2024 Nov; 133():104624. PubMed ID: 39426103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol).
    Hickman M; Dillon JF; Elliott L; De Angelis D; Vickerman P; Foster G; Donnan P; Eriksen A; Flowers P; Goldberg D; Hollingworth W; Ijaz S; Liddell D; Mandal S; Martin N; Beer LJZ; Drysdale K; Fraser H; Glass R; Graham L; Gunson RN; Hamilton E; Harris H; Harris M; Harris R; Heinsbroek E; Hope V; Horwood J; Inglis SK; Innes H; Lane A; Meadows J; McAuley A; Metcalfe C; Migchelsen S; Murray A; Myring G; Palmateer NE; Presanis A; Radley A; Ramsay M; Samartsidis P; Simmons R; Sinka K; Vojt G; Ward Z; Whiteley D; Yeung A; Hutchinson SJ
    BMJ Open; 2019 Sep; 9(9):e029538. PubMed ID: 31551376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptions of network based recruitment for hepatitis C testing and treatment among persons who inject drugs: a qualitative exploration.
    Ward KM; McCormick SD; Sulkowski M; Latkin C; Chander G; Falade-Nwulia O
    Int J Drug Policy; 2021 Feb; 88():103019. PubMed ID: 33160152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and facilitators to hepatitis C screening and treatment for people with lived experience of homelessness: A mixed-methods systematic review.
    Paisi M; Crombag N; Burns L; Bogaerts A; Withers L; Bates L; Crowley D; Witton R; Shawe J
    Health Expect; 2022 Feb; 25(1):48-60. PubMed ID: 34862710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the way to Hepatitis C elimination in the Republic of Georgia-Barriers and facilitators for people who inject drugs for engaging in the treatment program: A formative qualitative study.
    Chikovani I; Ompad DC; Uchaneishvili M; Sulaberidze L; Sikharulidze K; Hagan H; Van Devanter NL
    PLoS One; 2019; 14(4):e0216123. PubMed ID: 31034530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected People Who Inject Drugs in Guangzhou, China: Implications for HCV Treatment Expansion.
    Chu CE; Wu F; He X; Zhou K; Cheng Y; Cai W; Geng E; Volberding P; Tucker JD
    Open Forum Infect Dis; 2016 Apr; 3(2):ofw065. PubMed ID: 27419150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.